Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 StudyMartin Köcher, Rolf‐Peter Mueller, Riccardo Soffietti et al.|Journal of Clinical Oncology|2010Cited by 2k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialMark R. Gilbert, Minesh P. Mehta, Terri S. Armstrong et al.|Journal of Clinical Oncology|2013Cited by 1.1k
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life ResultsRiccardo Soffietti, Andrew Bottomley, Martin Köcher et al.|Journal of Clinical Oncology|2012Cited by 645